585 related items for PubMed ID: 12063520
21. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
22. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A, Jacques L, Frith L.
Clin Drug Investig; 2008 Mar; 28(3):169-81. PubMed ID: 18266402
[Abstract] [Full Text] [Related]
23. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
[Abstract] [Full Text] [Related]
24. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
[Abstract] [Full Text] [Related]
25. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Edin HM, Andersen LB, Schoaf L, Scott-Wilson CA, Ho SY, Ortega HG.
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
[Abstract] [Full Text] [Related]
26. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[Abstract] [Full Text] [Related]
27. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.
Ind PW, Dal Negro R, Colman NC, Fletcher CP, Browning D, James MH.
Respir Med; 2003 May; 97(5):555-62. PubMed ID: 12735675
[Abstract] [Full Text] [Related]
28. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma.
Robroeks CM, van de Kant KD, van Vliet D, Kester AD, Hendriks HJ, Damoiseaux JG, Wodzig WK, Rijkers GT, Dompeling E, Jöbsis Q.
Ann Allergy Asthma Immunol; 2008 Jun; 100(6):601-7. PubMed ID: 18592826
[Abstract] [Full Text] [Related]
29. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
Bergmann KC, Lindemann L, Braun R, Steinkamp G.
Swiss Med Wkly; 2004 Jan 24; 134(3-4):50-8. PubMed ID: 14745658
[Abstract] [Full Text] [Related]
30. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
Chest; 2005 Mar 24; 127(3):851-60. PubMed ID: 15764767
[Abstract] [Full Text] [Related]
31. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul 24; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
32. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
Worth H, Muir JF, Pieters WR.
Respiration; 2001 Jul 24; 68(5):517-26. PubMed ID: 11694816
[Abstract] [Full Text] [Related]
33. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
Chest; 1999 Sep 24; 116(3):625-32. PubMed ID: 10492263
[Abstract] [Full Text] [Related]
34. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ, Cates CJ, Jones AB, Steele EH, White J.
Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005309. PubMed ID: 16235400
[Abstract] [Full Text] [Related]
35. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA, Asthma Clinical Research Network of the National Heart Lung, and Blood Institute.
J Allergy Clin Immunol; 2002 Mar 19; 109(3):410-8. PubMed ID: 11897984
[Abstract] [Full Text] [Related]
36. Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective.
Paggiaro P, Patel S, Nicolini G, Pradelli L, Zaniolo O, Papi A.
Respir Med; 2013 Oct 19; 107(10):1531-7. PubMed ID: 23916740
[Abstract] [Full Text] [Related]
37. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF, Buist AS.
Chest; 1999 Nov 19; 116(5):1297-303. PubMed ID: 10559091
[Abstract] [Full Text] [Related]
38. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
Can Respir J; 1999 Nov 19; 6(1):45-51. PubMed ID: 10202220
[Abstract] [Full Text] [Related]
39. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A, Richter A, Oster H, Criée CP.
J Physiol Pharmacol; 2007 Nov 19; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[Abstract] [Full Text] [Related]
40. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ, Cates CK, Jones AB, Steele EH, White J.
Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD005309. PubMed ID: 16625634
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
